Press releases

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

MINNEAPOLIS AND DUBLIN, Ireland - Dec. 4, 2014 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the Chinese Ministry of Commerce has cleared Medtronic's proposed...

MINNEAPOLIS AND DUBLIN, Ireland - Dec. 4, 2014 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the Chinese Ministry of Commerce has cleared Medtronic's proposed...

DUBLIN, Ireland--(BUSINESS WIRE)--Dec. 4, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...

MINNEAPOLIS - December 4, 2014 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.305 per share of the Company's common stock. The dividend is payable on...

MINNEAPOLIS - December 1, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the pricing of $17 billion aggregate principal amount of senior notes in seven tranches, as follows: Description Amount...

MINNEAPOLIS - Nov. 3, 2014 - Optimizing the treatment of coronary artery disease with a new foundation for future stent innovations, Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité Europé

MINNEAPOLIS AND DUBLIN, Ireland – Nov. 28, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the European Commission has conditionally cleared Medtronic’s...

MINNEAPOLIS AND DUBLIN, Ireland - Nov. 26, 2014 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced the receipt of U.S. Federal Trade Commission (FTC) clearance of...

DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 24, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for its Fortrex™ over-the-wire (OTW) percutaneous...